Novartis announced a new strategy to broaden patient reach and availability of its portfolio of medicines in sub-Saharan Africa (SSA), which is home to the largest underserved patient population in the world. Novartis also aspires to be the partner of choice for governments and NGOs to strengthen healthcare systems across Africa. Read the full press release HERE.
Novartis announces new strategy to provide innovative medicines to more patients in sub-Saharan Africa
November 25, 2019